Exploring patient participation in reducing health-care-related safety risks

More documents

Recommendations

Info

Exploring patient participation in reducing health-care-related safety risks 54 Fig . 4 .5 . Patient safety in France Ministry of Health HAS IGAS AFSSAPS InVS EFS EXECUTIVE BRANCH ABM DGS DGOS DREES ANSES INPES INCa » ABM is the Agency of Biomedicine » AFSSAPS is the French Health Products Safety Agency » ANSES is the French Agency for Food, Environmental and Occupational Health Safety » DGOS, Direction Générale de l’Offre de Soins, is in charge of the organization of health care (to ensure its quality, continuity and accessibility) and health care professionals’ training and activities » DGS, within the Ministry of Health, is the authority responsible for prevention and health safety policies » DREES is responsible for providing the general public, authorities and representatives with reliable data and analyses on demographic features and health and social policies » EFS is the French Blood Transfusion Organization » HAS is the French National Authority for Health and is in charge of health care organizations and accreditation of professionals, safety of procedures, safety recommendations and patient information » IGAS is the Interministerial Audit and Evaluation Office for Social and Health, Employment and Labour Policies; its role is to assist public players in making informed decisions » INCa is the French National Cancer Institute » INPES is the French National Institute for Prevention and Health Education, in charge of health education and prevention » InVS is the French National Institute for Public Health Surveillance Source: the authors, based on HAS data. body was set up, chaired by a representative of patients’ organizations, with the aim of influencing decision-making and policy-making processes, and a new health information web site is being developed. It is worth noting that patients’ common rights, including informed consent, provision of information and access to medical records, also apply to blood transfusion. Transfusion and haemovigilance organization in France The overall goal of haemovigilance is to increase the safety and quality of blood transfusion (Article R1221-22). According to Decree No. 2006-99 (1 February 2006) relating to the blood transfusion centres and haemovigilance and modifying the Public Health Code (Article R1221-24), the national haemovigilance system consists of: » AFSSAPS; » National Haemovigilance Commission; » regional haemovigilance coordinators (mentioned in Article R1221-32); » EFS and the CTSA; » National Institute for Public Health Surveillance; and » health care facilities and armed forces hospitals (haemovigilance correspondents), transfusion safety and haemovigilance committees or facility medical commission
Blood transfusion safety in France: developing tools to support patients subcommissions; under Article R1221-43, a haemovigilance correspondent in each health facility must declare all adverse reactions in transfusion recipients and serious transfusion incidents and collect information mentioned in articles R1221-40 and R1221-2. A simplified depiction of the transfusion and haemovigilance system at national, regional and local levels is shown in Fig. 4.6 (6). Fig . 4 .6 . Organization of transfusion and haemovigilance in France Ministry of Health National AFSSAPS Regional EFS and CTSH 18 blood transfusion centres National Haemovigilance Commission 29 regional haemovigilance coordinators Local 155 transfusion sites 1 600 health care centres Health care professionals The transfusion safety and haemovigilance committees, created in 1994, are responsible for improving transfusion safety through research and consequent recommendations. Their duties at local level are to improve safety for transfused patients, monitor the application of haemovigilance regulations and manage the training of staff members dealing with blood transfusion processes (10). Any health care professional who observes or becomes aware of an adverse effect or a serious incident must report it within eight hours. Analysis of haemovigilance data is carried out at national level. Regulatory aspects and legal tools supporting patient safety and the right to safety in France List of official legislative documents Law No. 2002-303 8 on patients’ rights and quality of the health system came into force in 2002. This law gives the right to every hospitalized individual over 18 years of age to name a trustworthy person who will back them during their stay and defines the right for patients to access their medical records. In relation to blood transfusion, the 11 January 2006 bill 9 (repealed on 1 October 2006) abolished the systematization of pre- and post-serological transfusion checks on LBP recipients. 8 Loi No. 2002-303 du 4 Mars 2002; see the list of legislation at the end of this chapter. 9 Circulaire DGS/DHOS/SD3/2006/11 du 11 Janvier 2006. National Institute for Public Health Surveillance Epidemiology of donors 55
Page 1 and 2:
Exploring patient participation in
Page 3 and 4:
ABSTRACT Patients’ rights have be
Page 5 and 6:
iv Patient information: the link be
Page 7 and 8:
vi LIST OF TABLES, FIGURES AND BOXE
Page 9 and 10:
ACKNOWLEDGEMENTS The editors would
Page 11 and 12:
LIST OF ABBREVIATIONS ABHR alcohol-
Page 13 and 14:
FOREWORD Health is a social value a
Page 15 and 16:
ChApTER 1. pATIENTS’ RIGhTS AND p
Page 17 and 18: Box 1 .1 . contd Reporting and Lear
Page 19 and 20: The causal mechanisms through which
Page 21 and 22: » be involved in routine monitorin
Page 23 and 24: elationships within the complex env
Page 25 and 26: ChApTER 2. pATIENTS’ RIGhTS AND p
Page 27 and 28: CoE Recommendation 2006/7 of the Co
Page 29 and 30: The 2005 United States act on patie
Page 31 and 32: The right to participate in policy-
Page 33 and 34: The right to participate in quality
Page 35 and 36: » engaging with patient representa
Page 37 and 38: hampered by the written and spoken
Page 39 and 40: prevents misunderstandings and shap
Page 41 and 42: Health care providers should nevert
Page 43 and 44: Recommendation 7 - Encourage the av
Page 45 and 46: 20. Constitution of the World Healt
Page 47 and 48: ChApTER 3. pATIENT pARTICIpATION IN
Page 49 and 50: awareness of the sociomedical burde
Page 51 and 52: Patient participation in hand hygie
Page 61 and 62: Blood transfusion safety in France:
Page 65 and 66: Box 4 .1 . Definitions of adverse e
Page 67: Fig . 4 .4 . Distribution of advers
Page 73 and 74: The heterogeneity of situations and
Page 83 and 84: Fig . 4 .12 . Patients’ response
Page 91 and 92: Patient safety, rights and medicati
Page 97 and 98: Fig . 5 .3 . Frequency with which d
Page 107 and 108: ChApTER 6. pATIENT pARTICIpATION IN
Page 109 and 110: Patient participation in elective s
Page 111 and 112: e desirable to have a special statu
Page 117 and 118: inspections of surgical services to
Page 119 and 120:
Patient participation in elective s
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
» being involved in monitoring and
Page 135 and 136:
Other studies on patient attitudes
Page 137 and 138:
Information about patients’ exper
Page 139 and 140:
available evidence suggests that in
Page 141 and 142:
Adverse events Respondents from the
Page 143 and 144:
Feeling safe Five per cent of hospi
Page 145 and 146:
probability proportional to populat
Page 147 and 148:
care professionals’ and patients
Page 149 and 150:
group recommends that patient invol
Page 151 and 152:
13. Hibbard JH et al. Can patients
Page 153 and 154:
52. Triemstra M et al. Measuring cl
Page 155 and 156:
2009 (http://www.bradfordresearch.n
Page 157 and 158:
of a small-scale patient survey add
Page 159 and 160:
Box 8 .2 . Curricula and CME Chapte
Page 161 and 162:
is provided through interaction of
Page 163 and 164:
Box 8 .4 . Patient education Chapte
Page 165 and 166:
ANNEX 1. QUOTATIONS FROM INTERNATIO
Page 167 and 168:
(2) When designing adverse event re
Page 169 and 170:
17) If yes, do you think this was m
Page 171 and 172:
Box A3 .1 . Reporting procedure Pat
Page 173 and 174:
Box A3 .2 . contd Haemosiderosis Ha
Page 175 and 176:
ANNEX 4. pATIENT QUESTIONNAIRE ABOU
Page 177 and 178:
ANNEX 6. WhO pATIENT SAFETY pROGRAM
Page 179 and 180:
especially those in intensive care.
Page 181 and 182:
ANNEX 7. hANDOVER pROjECT Paul Bara
Page 183 and 184:
(a) Provide new insight into the ro
Page 185 and 186:
Johnson J, Barach P. Handovers of p
Page 187 and 188:
Enhancing the patients’ role in p
Page 189 and 190:
Enhancing the patients’ role in p
show all

Exploring patient participation in reducing health-care-related safety risks

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?